U.S. Retail REITs Stock News

Recent Move in Enact Holdings Stock Enact Holdings (ACT) has drawn fresh attention after recent trading left the stock at $46.52, with gains over the past week, month, and past three months prompting investors to reassess its valuation. See our latest analysis for Enact Holdings. The recent move in Enact Holdings comes on top of a 17.42% year to date share price return and a 36.42% total shareholder return over the past year. The 3 year total shareholder return of 92.56% points to strong long...

In recent coverage, analysts highlighted Loar Holdings as a top small defense stock, citing its positioning within the aerospace and defense equipment industry and support from rising U.S. defense budgets and geopolitical tensions. An interesting angle is that Loar sits alongside peers like Mercury Systems and Outdoor Holding in earning a top Zacks Rank, reflecting particularly strong analyst enthusiasm around its earnings outlook and sector role. Next, we’ll examine how this heightened...

The Marzetti Company has appointed Mark Carter as Chief Supply Chain Officer, effective July 13, 2026, succeeding Luis Viso ahead of his planned retirement and placing Carter in charge of the company’s end-to-end supply chain, safety, and quality functions. Carter’s long tenure leading complex supply chains at Schwan’s and Unilever introduces fresh operational expertise that could be important for Marzetti’s efficiency, product availability, and service levels across its retail and...

After a powerful 3 year run, AZZ stock is now facing a clear valuation tension. The Discounted Cash Flow (DCF) based intrinsic value suggests the shares trade at a premium, while market based checks point to something closer to a fair price. That mix sits alongside a low overall value score, which signals AZZ may not screen as a straightforward bargain despite its strong share price performance. AZZ has delivered a very large 3 year return of about 247%, which puts extra focus on whether the...

Travelers Companies (TRV) has put up another solid quarter, with Q2 2026 revenue of US$12.2 billion, basic EPS of US$10.42 and net income of US$2.2 billion framing the latest set of numbers. Over the past year, the company has seen revenue hold around the US$48.0 billion mark on a trailing twelve month basis. Over the same period, trailing EPS has moved to US$37.91, giving investors a clearer picture of the earnings power behind the current US$368.98 share price. With a Q2 combined ratio of...

South Plains Financial (SPFI) opened Q2 2026 with total revenue of US$64.1 million and basic EPS of US$0.99, putting fresh numbers on the table for investors watching its profitability story. The company reported quarterly revenue of US$52.2 million in Q2 2025 and US$64.1 million in Q2 2026, while basic EPS was US$0.90 and US$0.99 over the same periods, providing a reference point for how the top and bottom lines are tracking into this year. With these results, attention turns to how South...

Markets are sending mixed signals right now, with softer inflation readings, uneven housing data and shifting global bond flows all pulling your portfolio in different directions. When headlines are noisy, low risk leaders with strong balance sheets can help you stay invested without leaning on guesswork about the next macro swing. Our Low-Risk Leaders screener focuses on companies that our model scores as having the lowest risk profiles, so you can concentrate on resilient businesses instead...

PNC Financial Services Group has delivered a strong 108.8% share price return over the past 3 years, and the current valuation picture now hinges on how that rally lines up with its intrinsic value estimate and broader checks. The 108.8% 3 year return suggests investors have already priced in a meaningful improvement in PNC Financial Services Group's earnings power. Recent earnings growth, a higher dividend, and ongoing technology investment can support higher valuations, while integration...

Kura Oncology previously announced that updated Phase 1a results from its FIT-001 trial of darlifarnib plus cabozantinib in advanced renal cell carcinoma were selected for an oral presentation at the 2026 Kidney Cancer Research Summit in Boston. The data highlight darlifarnib’s potential to enhance VEGFR-targeted therapies by inhibiting adaptive mTORC1 signaling, supporting Kura’s plan to position it as a precision combination backbone across multiple targeted therapy classes. We’ll now...

New York’s one year moratorium on environmental permits for large data centers has pushed power constraints into focus, putting Constellation Energy (CEG) under closer investor scrutiny as AI driven electricity demand meets regulatory limits. See our latest analysis for Constellation Energy. Constellation Energy’s share price has cooled recently, with the stock down 7.9% over the past month and 12.2% over the past quarter, while its 1 year total shareholder return is down 21.1% after a very...

Upcoming earnings and buyback program put TKO Group Holdings (TKO) in focus TKO Group Holdings (TKO) heads into its August 3 fiscal 2026 Q2 earnings release with investor attention on forecasts for a 47% profit per share increase and an $800 million accelerated share repurchase that was recently completed. See our latest analysis for TKO Group Holdings. At a share price of $185.13, TKO Group Holdings has seen its short term momentum cool, with a 30 day share price return of negative 6.87%...

SELLAS Life Sciences Group stock has delivered a very large three year return while the broader valuation checks suggest the shares are expensive rather than a clear bargain. Over the past three years, SELLAS Life Sciences Group has returned about 7x, which puts extra attention on whether the current price already reflects much of the good news. Expectations for rapid revenue and earnings growth may support the current valuation, while the recently filed US$154.6m shelf registration...

Tariff headlines are no longer just background noise for investors. With trans-Pacific shipping demand cooling, freight rates under pressure and importers hesitating on orders, the latest round of U.S. trade uncertainty is starting to bite specific stocks tied to Asia to U.S. supply chains. For some companies, stalled shipments and a pulled-forward peak season could mean tougher volumes, uneven pricing power and more complex inventory choices. This article explains how that news risk affects...

Hingham Institution for Savings (HIFS) opened Q2 2026 with total revenue of US$42.4 million and basic EPS of US$11.59, supported by net income of US$25.4 million, setting a clear earnings tone for the quarter. The bank has seen quarterly revenue move from US$20.4 million and EPS of US$4.32 in Q2 2025 to US$34.5 million with EPS of US$9.49 in Q4 2025, before reaching the latest Q2 2026 levels, while trailing twelve month EPS stood at US$30.33 on revenue of US$119.5 million. With a reported net...

Gibraltar Industries (NasdaqGS:ROCK) has completed the sale of its Renewables business. The company is repositioning around core markets including residential, agtech, and infrastructure. The transaction reshapes Gibraltar Industries’ business mix and long term focus. The exit from renewables marks a clear refocus for Gibraltar Industries, which now centers its portfolio on residential products, controlled environment agriculture, and infrastructure solutions. For investors, this means the...

Sionna Therapeutics stock has delivered a sharp 195.2% return over the past year, yet its low value score and overvalued reading on the market multiples raise questions about how much upside is already reflected in the price. Over the past 1 year, Sionna Therapeutics has returned 195.2%, which puts the recent share price strength firmly in focus for anyone thinking about valuation. Expectations for the company’s drug pipeline can support a premium, but uncertainty around execution,...

Travel + Leisure stock has delivered a 96.3% return over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings-based multiples still point to the shares trading at a discount to what the business may be worth. With the stock recently at US$73.27 and fresh acquisition news in play, the central question is whether the current price already reflects that upside. Over the last three years, Travel + Leisure has returned 96.3%, which puts extra focus...

CareDx, Inc. recently secured a final Medicare Local Coverage Determination that confirms and aligns reimbursement for its AlloSure and AlloMap transplant surveillance tests in kidney, heart, and lung, including defined test frequencies for the critical first three years post-transplant. This decision reduces reimbursement uncertainty and more closely matches actual clinical testing patterns, potentially giving CareDx clearer visibility into demand and test utilization across its transplant...

Earlier this year, Revolve Group reported strong Q1 results, with revenue coming in 4.2% above analyst expectations and its buyer base expanding, which management linked to effective execution and market share gains. This combination of outperformance and customer growth suggests the company’s efforts in merchandising, marketing, and technology are translating into tangible operating momentum. Now we’ll explore how this revenue beat and expanding customer base may influence Revolve Group’s...

Regions Financial (RF) opened Q2 2026 with total revenue of US$1,839 million and basic EPS of US$0.64, supported by net income excluding extra items of US$549 million. The company has seen quarterly revenue move from US$1,779 million in Q2 2025 to US$1,839 million in Q2 2026, while basic EPS shifted from US$0.59 to US$0.64 over the same period, giving investors a clearer view of how the income line is tracking. With a trailing net profit margin of 29.7% and a net interest margin of 3.66%, the...

CSW Industrials stock has delivered a strong 145.0% return over the past 5 years, yet current checks point to shares trading at a premium, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples indicating the valuation may be ahead of the fundamentals. Over 5 years, CSW Industrials has returned 145.0%, which puts more focus on whether the current share price already reflects much of the company’s progress. Expectations for CSW Industrials to keep converting...

Pinnacle Financial Partners stock has delivered a 49.6% total return over the past three years, yet on current checks it screens as only a low-score value pick, while the Excess Returns intrinsic value estimate suggests the shares trade at a steep discount to fair value. That tension between a solid multi year return, an intrinsic value signal implying 42.1% upside and broader checks that lean cautious is what investors now have to weigh. A 49.6% return over three years points to a stock...

Sarepta Therapeutics stock is coming off a long period of weak share price performance, with a steep decline over the past three years sitting alongside a mixed valuation profile and fresh regulatory progress that could influence how investors think about what the shares are worth today. Over the past three years, Sarepta Therapeutics has fallen 83.7%, which places the current valuation in the context of a prolonged drawdown rather than a recent rally. The FDA’s acceptance of supplemental...

Tech stocks, including DoubleVerify Holdings (DV), came under pressure after an oil shock and a renewed U.S. naval blockade on Iran raised concerns about prolonged higher interest rates and tighter funding conditions. See our latest analysis for DoubleVerify Holdings. The latest pullback in DoubleVerify Holdings reflects the broader risk-off mood in tech, with the stock down 3.22% on a 1 day share price return basis and 2.14% over 7 days. Its 30 day share price return of 10.55% and year to...